Literature DB >> 8806594

Integrin beta 3 cDNA transfection into a highly metastatic alpha v beta 3-negative human melanoma cell line inhibits invasion and experimental metastasis.

E H Danen1, A A van Kraats, I M Cornelissen, D J Ruiter, G N van Muijen.   

Abstract

Even though integrin alpha v beta 3 is thought to play a role in invasive growth of melanomas, some metastatic melanoma cell lines lack alpha v beta 3, and downmodulation of alpha v beta 3, expression can enhance the invasive capacity of certain melanoma cells. To further investigate this apparent dualistic role of alpha v beta 3, we transfected beta 3 cDNA into the highly metastatic, beta 3-negative human melanoma cell line MV3. MV3 cells adhered to fibronectin but not to fibrinogen or a synthetic RGD peptide, while MV3-beta 3 adhered to all three RGD-containing adhesive ligands, and this adhesion was inhibited by LM609 alpha v beta 3 mAb. Expression of alpha v beta 3 did not affect MV3 in vitro proliferation or in vivo tumorigenicity upon subcutaneous inoculation into nude mice. In contrast, it strongly reduced invasion in matrigel and lung colonization in nude mice of MV3 cells. Thus, certain melanoma cell lines have adopted a metastatic strategy in the absence of alpha v beta 3, and in such cells expression of this integrin leads to a less aggressive phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806594     DOI: 10.1006/bbrc.1996.1313

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma.

Authors:  M Y Hsu; D T Shih; F E Meier; P Van Belle; J Y Hsu; D E Elder; C A Buck; M Herlyn
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

2.  beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter.

Authors:  S Hapke; M Gawaz; K Dehne; J Köhler; J F Marshall; H Graeff; M Schmitt; U Reuning; E Lengyel
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 3.  Integrins in cancer: biological implications and therapeutic opportunities.

Authors:  Jay S Desgrosellier; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

4.  Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells.

Authors:  Yunlong Lei; Kai Huang; Cong Gao; Quek Choon Lau; Hua Pan; Ke Xie; Jingyi Li; Rui Liu; Tao Zhang; Na Xie; Huey Shan Nai; Hong Wu; Qiang Dong; Xia Zhao; Edouard C Nice; Canhua Huang; Yuquan Wei
Journal:  Mol Cell Proteomics       Date:  2011-05-27       Impact factor: 5.911

5.  alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression.

Authors:  A Lochter; M Navre; Z Werb; M J Bissell
Journal:  Mol Biol Cell       Date:  1999-02       Impact factor: 4.138

6.  {beta}3-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer.

Authors:  Swayamjot Kaur; Hilary A Kenny; Sujatha Jagadeeswaran; Marion R Zillhardt; Anthony G Montag; Emily Kistner; S Diane Yamada; Anirban K Mitra; Ernst Lengyel
Journal:  Am J Pathol       Date:  2009-10-01       Impact factor: 4.307

7.  The fibronectin-binding integrins alpha5beta1 and alphavbeta3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis.

Authors:  Erik H J Danen; Petra Sonneveld; Cord Brakebusch; Reinhard Fassler; Arnoud Sonnenberg
Journal:  J Cell Biol       Date:  2002-12-16       Impact factor: 10.539

8.  Rice callus suspension culture inhibits growth of cell lines of multiple cancer types and induces apoptosis in lung cancer cell line.

Authors:  Nafeesa Rahman; Surendar Reddy Dhadi; Aparna Deshpande; Wusirika Ramakrishna
Journal:  BMC Complement Altern Med       Date:  2016-11-02       Impact factor: 3.659

Review 9.  Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells.

Authors:  Yosi Gilad; Michael Firer; Gary Gellerman
Journal:  Biomedicines       Date:  2016-05-26

Review 10.  Occupy tissue: the movement in cancer metastasis.

Authors:  Peta Bradbury; Ben Fabry; Geraldine M O'Neill
Journal:  Cell Adh Migr       Date:  2012-09-01       Impact factor: 3.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.